PsycReality Company Profile

Background

Overview

PsycReality, operating under the legal name Cognitology Limited, is an innovative company based in Dublin, Ireland, specializing in the application of immersive technologies to enhance mental health treatments. Founded in 2018, the company focuses on leveraging Virtual Reality (VR), Artificial Intelligence (AI), Augmented Reality (AR), Haptic feedback, and EEG technologies to assist mental health professionals in treating conditions such as anxiety, phobias, and trauma.

Mission and Vision

PsycReality's mission is to improve individuals' mental health and well-being by integrating advanced technologies into therapeutic practices. The company envisions a future where immersive technologies are standard tools for mental health professionals, leading to more effective and efficient treatments for patients worldwide.

Industry Significance

In 2025, PsycReality was recognized as the "Most Innovative VR-Based Medical Solutions CEO" in the UK & Ireland by the European CEO of the Year Awards, highlighting its significant impact in the field of mental health technology.

Key Strategic Focus

Core Objectives

PsycReality aims to revolutionize mental health treatment by providing therapists with immersive tools that replicate real-life scenarios, thereby enhancing the effectiveness and efficiency of therapeutic interventions.

Areas of Specialization

The company specializes in developing VR-based solutions that enable therapists to expose patients to controlled, virtual environments, facilitating the treatment of various mental health conditions, including social anxiety, phobias, and trauma.

Key Technologies Utilized

Virtual Reality (VR): Creates immersive environments for exposure therapy.

Artificial Intelligence (AI): Personalizes treatment plans based on patient responses.

Augmented Reality (AR): Enhances real-world interactions with virtual elements.

Haptic Feedback: Provides tactile sensations to simulate real-world experiences.

EEG Technology: Monitors brain activity to assess patient responses.

Primary Markets Targeted

PsycReality primarily targets mental health professionals, including psychologists and therapists, as well as clinics and hospitals that offer psychological services. The company has expanded its reach to the Middle East, forming partnerships with institutions such as the University of Birmingham, Heriot-Watt University, and the Middle East Psychological Association to advance psychology research and clinical care.

Financials and Funding

Funding History

PsycReality has raised between €100K and €500K in funding to date.

Recent Funding Rounds

The company is actively seeking additional investment to accelerate the development of its VR-based therapeutic solutions and to expand its research initiatives. Potential investors are offered preferential rates for a period following their investment.

Notable Investors

Specific details about individual investors are not publicly disclosed.

Utilization of Capital

The raised funds are intended to enhance the development of immersive video software, conduct ongoing research into emerging technologies, and expand the company's reach in the mental health sector.

Pipeline Development

Key Pipeline Candidates

PsycReality is developing a suite of VR-based therapeutic modules targeting various phobias and anxiety disorders. These modules are designed to provide controlled exposure therapy through immersive virtual environments.

Stages of Development

The company has completed initial clinical trials demonstrating the effectiveness of its VR-based treatments. Ongoing development focuses on refining these modules and expanding their applicability to a broader range of mental health conditions.

Target Conditions

The primary focus is on treating social anxiety, phobias, and trauma-related disorders.

Anticipated Milestones

PsycReality plans to launch its therapeutic modules commercially in the fourth quarter of this year, aiming to generate revenue and establish a foothold in the market.

Technological Platform and Innovation

Proprietary Technologies

PsycReality has developed proprietary VR-based therapeutic modules that integrate AI, AR, Haptic feedback, and EEG technologies to create immersive and personalized treatment experiences.

Significant Scientific Methods

Immersive Exposure Therapy: Utilizes VR to simulate real-life scenarios for controlled exposure.

AI-Driven Personalization: Adapts treatment plans based on real-time patient data.

Haptic Feedback Integration: Enhances realism by providing tactile sensations.

EEG Monitoring: Assesses brain activity to evaluate patient responses.

Leadership Team

Bilal Awan – CEO

Bilal Awan is the founder and CEO of PsycReality. A multi-award-winning entrepreneur and technologist, he has been recognized for his innovative contributions to the tech industry. Under his leadership, PsycReality has developed cutting-edge VR-based therapeutic solutions and established strategic partnerships with academic and clinical institutions.

Competitor Profile

Market Insights and Dynamics

The market for VR-based mental health treatments is expanding, driven by increasing awareness of mental health issues and the effectiveness of immersive therapies. PsycReality faces competition from other companies developing similar technologies, such as FundamentalVR, Karuna Labs, and OxfordVR, which offer VR-based solutions for mental health and medical training.

Competitor Analysis

FundamentalVR: Provides VR simulations for surgical training, accredited by the Royal College of Surgeons of England.

Karuna Labs: Offers HIPAA-compliant VR treatments for chronic pain, FDA-registered.

OxfordVR: Develops VR solutions for mental health, with partnerships including the UK's National Health Service.

Strategic Collaborations and Partnerships

PsycReality has formed strategic partnerships with the University of Birmingham, Heriot-Watt University, and the Middle East Psychological Association to advance psychology research and clinical care.

Operational Insights

PsycReality differentiates itself by offering a comprehensive suite of VR-based therapeutic modules that integrate multiple immersive technologies, providing a more holistic treatment approach compared to competitors.

Strategic Opportunities and Future Directions

The company plans to expand its product offerings to address a wider range of mental health conditions and to enter new markets, including North America and Oceania. Ongoing research and development aim to enhance the effectiveness and accessibility of its therapeutic solutions.